Morgan Stanley Reiterates Equal-Weight Rating on The Clorox Company on Strong Q2 EPS

In a report published Monday, Morgan Stanley reiterated its Equal-Weight rating on The Clorox Company (NYSE: CLX ). Morgan Stanley noted, “Clorox 2Q EPS of $0.93 ($0.90 ex-item) were well ahead of the $0.81 consensus. Q2 was above consensus across the board with 4% revenue, 5% gross profit, and +12%